Pricing Log in Create free account

IDEAYA Biosciences, Inc. (IDYA) vs Telix Pharmaceuticals Limited (TLX)

IDEAYA Biosciences, Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. IDEAYA Biosciences, Inc. and Telix Pharmaceuticals Limited are of similar size ($3.2B and $3.0B). Across the 9 metrics below, Telix Pharmaceuticals Limited leads on 5 and IDEAYA Biosciences, Inc. on 4.

Valuation

Metric IDYA TLX Biotechnology median
P/E n/m — 10.26
P/S 86.70 — 9.18
P/B 2.90 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 63.75 n/m 8.98
Earnings yield (14.60%) — (34.89%)
Free cash flow yield (11.04%) 0.00% (24.52%)

Profitability

Metric IDYA TLX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (1,267.38%) — 0.00%
Net margin (1,149.62%) — 0.00%
Free cash flow margin (957.43%) 0.00% 0.00%
Return on equity (38.46%) 0.00% (50.12%)
Return on assets (34.98%) 0.00% (45.60%)
Return on invested capital (114.15%) 0.00% 0.00%

Growth

Metric IDYA TLX Biotechnology median
Revenue growth (TTM) (83.64%) — 6.26%
EPS growth (last fiscal year) 61.90% (120.00%) 29.88%
Revenue growth, 5-year CAGR 62.11% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IDYA TLX Biotechnology median
Debt to equity 0.00 1.18 0.00
Current ratio 9.04 2.01 4.89
Net debt to EBITDA 3.88 6.25 1.01

Dividend

Metric IDYA TLX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IDYA TLX Biotechnology median
Market cap 2.96b 3.21b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack